TCL Archive Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients October 29, 2010
TCL Archive NCI Opens Negotiations With Litton-Bionetics For Renewal of $10 Million Frederick Contract March 1, 1974
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
TCL Archive In Brief – Control Of Many Cancer Forms By End Of The Century, Frederickson Tells House Committee April 6, 1979
